scholarly article | Q13442814 |
P50 | author | Po-Chao Wen | Q58140638 |
Susan B. Rempe | Q88213004 | ||
Emad Tajkhorshid | Q28052921 | ||
P2093 | author name string | Juan M Vanegas | |
P2860 | cites work | Synthesis and structure-activity relationship of teixobactin analogues via convergent Ser ligation | Q61779084 |
Isolation and characterization of hypeptin from Pseudomonas sp | Q69785404 | ||
Lipopeptidomimetics derived from teixobactin have potent antibacterial activity against Staphylococcus aureus | Q87891234 | ||
Developing Equipotent Teixobactin Analogues against Drug-Resistant Bacteria and Discovering a Hydrophobic Interaction between Lipid II and Teixobactin | Q88305286 | ||
Design and syntheses of highly potent teixobactin analogues against Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE) in vitro and in vivo | Q49030931 | ||
Efficient total syntheses and biological activities of two teixobactin analogues | Q49064838 | ||
Synthesis and antibacterial studies of teixobactin analogues with non-isostere substitution of enduracididine | Q49341522 | ||
Synthesis and biological evaluation of novel teixobactin analogues | Q49376250 | ||
Syntheses of potent teixobactin analogues against methicillin-resistant Staphylococcus aureus (MRSA) through the replacement of l-allo-enduracididine with its isosteres. | Q50560970 | ||
Teixobactin analogues reveal enduracididine to be non-essential for highly potent antibacterial activity and lipid II binding. | Q52641511 | ||
Multiple attack on bacteria by the new antibiotic teixobactin. | Q52866776 | ||
Synthesis and Biological Evaluation of a Teixobactin Analogue. | Q53181587 | ||
Rational design and synthesis of modified teixobactin analogues: in vitro antibacterial activity against Staphylococcus aureus, Propionibacterium acnes and Pseudomonas aeruginosa. | Q54217425 | ||
Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors. | Q54340087 | ||
Bacterial lipid composition and the antimicrobial efficacy of cationic steroid compounds (Ceragenins). | Q54438950 | ||
Wild-type Escherichia coli cells regulate the membrane lipid composition in a "window" between gel and non-lamellar structures. | Q54591793 | ||
Re-evaluation of the N-terminal substitution and the D-residues of teixobactin | Q57179926 | ||
Lysine Scanning of Arg-Teixobactin: Deciphering the Role of Hydrophobic and Hydrophilic Residues | Q58034891 | ||
A new antibiotic kills pathogens without detectable resistance | Q24091299 | ||
Structural insight into the transglycosylation step of bacterial cell-wall biosynthesis | Q27644008 | ||
Crystal structures of the complexes between vancomycin and cell-wall precursor analogs | Q27652716 | ||
Crystal structure of Staphylococcus aureus transglycosylase in complex with a lipid II analog and elucidation of peptidoglycan synthesis mechanism | Q27678437 | ||
High-resolution crystal structure reveals molecular details of target recognition by bacitracin | Q27679545 | ||
Targeting Antibiotic Resistance | Q28078130 | ||
MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens | Q28343810 | ||
Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types | Q29616710 | ||
Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity | Q31473388 | ||
Enhanced sampling and applications in protein folding in explicit solvent | Q34000996 | ||
CHARMM additive all-atom force field for carbohydrate derivatives and its utility in polysaccharide and carbohydrate-protein modeling. | Q34085563 | ||
The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics | Q34550741 | ||
At the membrane frontier: a prospectus on the remarkable evolutionary conservation of polyprenols and polyprenyl-phosphates. | Q35661322 | ||
The antibiotic resistance crisis, with a focus on the United States | Q36293305 | ||
Lipid II as a target for antibiotics | Q36419233 | ||
Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles | Q36546184 | ||
The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis | Q37081708 | ||
Elucidation of the Teixobactin Pharmacophore | Q37616543 | ||
Lipid-linked oligosaccharides in membranes sample conformations that facilitate binding to oligosaccharyltransferase | Q38302930 | ||
Bacterial membrane lipids: diversity in structures and pathways | Q38415713 | ||
Antibiotic innovation for future public health needs | Q38666414 | ||
New Found Hope for Antibiotic Discovery: Lipid II Inhibitors | Q38889355 | ||
Antimicrobial resistance in healthcare, agriculture and the environment: the biochemistry behind the headlines | Q39160453 | ||
Targeting a cell wall biosynthesis hot spot | Q39413308 | ||
Dual Targeting of Cell Wall Precursors by Teixobactin Leads to Cell Lysis. | Q40566928 | ||
Antibiotic effectiveness: balancing conservation against innovation | Q41741779 | ||
New insights into the mode of action of the lantibiotic salivaricin B. | Q41884008 | ||
Assembly and stability of nisin-lipid II pores | Q45045783 | ||
X-ray crystallographic structure of a teixobactin analogue reveals key interactions of the teixobactin pharmacophore. | Q46386811 | ||
Alanine scan reveals modifiable residues in teixobactin | Q46549407 | ||
Investigation of the N-Terminus Amino Function of Arg10-Teixobactin | Q46690045 | ||
Teixobactin as a scaffold for unlimited new antimicrobial peptides: SAR study. | Q46745179 | ||
Binding Modes of Teixobactin to Lipid II: Molecular Dynamics Study | Q47267177 | ||
Converting Teixobactin into a Cationic Antimicrobial Peptide (AMP). | Q47969690 | ||
Defining the molecular structure of teixobactin analogues and understanding their role in antibacterial activities | Q48310474 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 34 | |
P921 | main subject | teixobactin | Q18720369 |
lipid II | Q21099571 | ||
P304 | page(s) | 6997-7008 | |
P577 | publication date | 2018-07-20 | |
P1433 | published in | Chemical Science | Q2962267 |
P1476 | title | Probing key elements of teixobactin-lipid II interactions in membranes | |
P478 | volume | 9 |